Glucotrack, Inc. Files 8-K: Regulation FD & Financials
Ticker: GCTK · Form: 8-K · Filed: Oct 28, 2025 · CIK: 1506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | 8-K |
| Filed Date | Oct 28, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financials
TL;DR
Glucotrack filed an 8-K on Oct 28, 2025, covering Reg FD and financials. No major news yet.
AI Summary
On October 28, 2025, Glucotrack, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates Glucotrack, Inc. is providing updates related to regulatory disclosures and financial statements, which are important for investors to monitor company compliance and financial health.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for regulatory and financial disclosures, with no immediate indication of significant risk or material events.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- October 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-41141 (identifier) — Commission File Number
- 98-0668934 (identifier) — IRS Employer Identification No.
- 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070 (address) — Address of principal executive offices
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the excerpt.
What financial statements are included in this 8-K filing?
The filing states that Financial Statements and Exhibits are included, but the excerpt does not specify which financial statements.
When was Glucotrack, Inc. incorporated?
Glucotrack, Inc. was incorporated in Delaware.
What is the principal executive office address for Glucotrack, Inc.?
The principal executive office is located at 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070.
What is the Commission File Number for Glucotrack, Inc.?
The Commission File Number for Glucotrack, Inc. is 001-41141.
Filing Stats: 491 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-10-28 08:34:45
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share GCTK The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-25-019834.txt ( ) — 221KB
- gctk-20251028.xsd (EX-101.SCH) — 3KB
- gctk-20251028_lab.xml (EX-101.LAB) — 33KB
- gctk-20251028_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 28, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer